Evidence map›Paper›PMID 39972069›Full record

ArticleScientific reports2025

Fecal microbiota and genetics in pediatric-onset orofacial granulomatosis and Crohn´s disease.

Miikka Höyhtyä, Anu Haaramo, Anne Nikkonen, Rebecka Ventin-Holmberg, Nitin Agrawal, Jarmo Ritari, Brandon Hickman, Jukka Partanen, Heikki Alapulli, Jetta Tuokkola and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miikka HöyhtyäFaculty of Medicine, University of Helsinki, Helsinki, Finland.
Anu HaaramoDepartment of Otorhinolaryngology, Head and Neck Surgery, Helsinki University Hospital HUS and University of Helsinki, Helsinki, Finland.
Anne NikkonenChildren´S Hospital, University of Helsinki and HUS, Helsinki, Finland.
Rebecka Ventin-HolmbergHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Nitin AgrawalFin-HIT Research Group, Folkhälsan Research Center, Department of Public Health, Helsinki, Finland.
Jarmo RitariFinnish Red Cross Blood Service, Helsinki, Finland.
Brandon HickmanHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Jukka PartanenFinnish Red Cross Blood Service, Helsinki, Finland.
Heikki AlapulliDepartment of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki and Helsinki University Hospital HUS, Helsinki, Finland.
Jetta TuokkolaClinical Nutrition Unit, Internal Medicine and Rehabilitation, Institute of Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Anne SalonenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Willem M de VosHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kaija-Leena KolhoFaculty of Medicine, University of Helsinki, Helsinki, Finland. kaija-leena.kolho@helsinki.fi.

Funding

Helsingin ja Uudenmaan Sairaanhoitopiiri TYH2016224
6 · The paper itself

Abstract

Orofacial granulomatosis (OFG) is a rare chronic inflammatory condition. It is under debate, whether it is a condition of its own or merely a subtype of Crohn's disease (CD). We aimed to search for markers characteristic of patients with pediatric-onset OFG compared to patients with pediatric-onset CD. We recruited young patients with OFG (with or without CD, n = 29), CD (n = 24), and healthy controls (n = 20). All participants provided a fecal sample for microbiota and calprotectin analyses and saliva for DNA analysis of genes associated with OFG and kept a 3-day food diary. Oral disease activity was evaluated using The Oral Disease Activity Score by an otorhinolaryngologist and a dentist. We observed decreased relative abundance in class Clostridia and increased relative abundances of classes Actinobacteria and Bacilli in the feces of patients with OFG when compared to patients with CD and healthy controls. The relative abundances of Bifidobacterium adolescentis increased and Faecalibacterium prausnitzii decreased along with the increase in the Oral Disease Activity Score. We found the NOD2 gene rs8057341 allele A to be enriched in patients with OFG compared to patients with CD. These findings support the theory that OFG is a distinct disease phenotype.

Indexed as

Crohn DiseaseFecesGastrointestinal MicrobiomeGranulomatosis, OrofacialAdolescentCase-Control StudiesChildFemaleHumansLeukocyte L1 Antigen ComplexMaleMicrobiotaNod2 Signaling Adaptor ProteinSalivaLeukocyte L1 Antigen ComplexNOD2 protein, humanNod2 Signaling Adaptor ProteinChildrenGenotypeInflammatory bowel diseasesOral

Identifiers

PMID39972069
PMCPMC11839994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.